Voyager Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Voyager Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Voyager Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$36.6M, a 144% decline year-over-year.
  • Voyager Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$123M, a 1755% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$83.3M, a 168% decline from 2023.
  • Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $122M.
  • Voyager Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.8M, a 30.9% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$83.3M -$205M -168% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $122M +$173M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 -$50.8M +$22.8M +30.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-11
2021 -$73.6M -$101M -369% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $27.4M +$79.1M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-07
2019 -$51.7M +$39.4M +43.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 -$91.1M -$19.2M -26.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$71.9M -$30.6M -74% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 -$41.3M -$21M -104% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$20.3M -$5.89M -41% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$14.4M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.